Pfizer has agreed to supply five million doses of its Covid-19 vaccine to Sri Lanka under a commercial agreement with the State Pharmaceuticals Corporation (SPC), a Minister said yesterday.
State Minister of Production, Supply and Regulation of Pharmaceuticals Prof. Channa Jayasumana told the payment arrangement for the dispatch of Pfizer vaccines would be worked out later.
He said the dose of Pfizer vaccine was smaller than others, and therefore separate syringes will have to be arranged for administering it to people in the country. Besides, he said Sri Lanka had placed orders for 13 million doses of Sputnik V vaccine manufactured in Russia. It is a commercial arrangement between the SPC and Gamaleya Research Institute of Russia. The Minister said the Russian authorities would start the delivery process of the stock in batches starting from the end of this month.
“They will send us the stock in batches during the last week of every month starting from April,†he said. Asked about the regulatory clearance for China’s Sinopharm vaccine, he said it would be given immediately after the World Health Organization (WHO) listed it for emergency use. China has already donated 600,000 doses of this vaccine to Sri Lanka. Commenting on the Covid-19 situation, he said the health authorities were bracing for a spike of the cases by the next week.
President Anura Kumara Dissanayake stated that if the current government fails to meet the expectations…
There have been abuses in the issuance of permits for expatriate workers to import electric…
The International Monetary Fund (IMF) reached a staff level agreement with Sri Lankan authorities, paving…
Sri Lanka Embassy in Brussels participated at the European Parliament “Fair Trade Breakfast-2024”, on 13…
etstar Asia yesterday launched its Colombo-Singapore direct route positioning itself as the only low-cost carrier…
Solo travellers are getting older and are increasingly drawn to Asian destinations – with Sri…
View Comments
For India, Pfizer has offered a not-for-profit price for its vaccine for the Government immunization program. While Pfizer was the first company to seek emergency approval in India for its vaccine with BioNTech, its application was rejected because it had not conducted local trials in India.